MedPath

Remote Ischemic Preconditioning in Aortic Valve Surgery

Not Applicable
Completed
Conditions
Aortic Valve Stenosis
Interventions
Procedure: Control
Procedure: Remote ischemic preconditioning
Registration Number
NCT01390129
Lead Sponsor
University Hospital, Angers
Brief Summary

RIP-VALVE is a randomized, single blinded study that will test the hypothesis that remote ischemic preconditioning initiated before surgery reduces post-operative myocardial damage in aortic valve surgery. Infarct size will be determined by 72 hours area under curve of troponin-I.

Detailed Description

The hypothesis tested in this research proposal is that remote ischemic preconditioning initiated immediately before aortic valve surgery reduces myocardial damage related to surgery.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Age > 18
  • Aortic valve surgery for aortic stenosis
  • Written informed consent
Exclusion Criteria
  • Aortic valve surgery combined with CABG or an other valve surgery
  • Previous Q-wave myocardial infarction or previous coronary artery bypass graft
  • Coronary artery stenosis >70%
  • Ejection fraction <35%
  • Surgery performed in emergency
  • Nicorandil ou metformin treatment within 8 days before surgery
  • Patient refusal / patient not having provided written informed consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlControl-
Remote ischemic preconditioningRemote ischemic preconditioning-
Primary Outcome Measures
NameTimeMethod
Infarct size72 hours

Infarct size as assessed by 72 hours area under curve serum troponin-I

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital, Angers

🇫🇷

Angers, France

© Copyright 2025. All Rights Reserved by MedPath